Centrus Energy (LEU) Tests Its Valuation As Its Nuclear Gatekeeper Narrative Holds
Centrus Energy LEU | 0.00 |
Centrus Energy (LEU) supplies nuclear fuel components through its Low Enriched Uranium and Technical Solutions segments, giving investors exposure to utility focused contracts across the United States, Japan, the Netherlands, and other international markets.
At a share price of $156.05, Centrus Energy has seen the 1 day share price return rise 6.11%, but the share price return is down 18.46% over 30 days and 42.73% year to date. At the same time, the 3 year total shareholder return of about 3.6x highlights how longer term holders have still seen very large gains, suggesting recent weakness may reflect changing sentiment around growth prospects and risk rather than a simple break in the story.
If you are looking beyond Centrus Energy, this could be a useful moment to scan other nuclear fuel and infrastructure opportunities using the 90 nuclear energy infrastructure stocks
After Centrus Energy’s sharp pullback and with the stock trading well below the average analyst price target of about $264.73, where does a reasonable view of fair value actually land across the current spread of estimates?
Most Popular Narrative: 74% Undervalued
On the latest numbers, the prevailing narrative pegs Centrus Energy’s fair value at $609.90, far above the last close of $156.05. This frames today’s gap between market price and narrative expectations.
Centrus Energy is one of those rare companies whose importance becomes clearer the deeper you look into the machinery of U.S. law, national security, and nuclear policy. In a sector defined by scarcity, Centrus isn’t just another uranium company; it is the only U.S. company legally authorized to enrich uranium for the federal government, a distinction rooted directly in federal statute. Under 10 U.S.C. § 2538a, the U.S. government is prohibited from purchasing enriched uranium for defense purposes from any entity that is not a U.S.-owned, U.S.-operated, and NRC licensed enricher. That legal filter leaves exactly one company standing, Centrus. This is before you even get to the fact that Centrus is also the only firm with an NRC license to produce HALEU, the fuel required for nearly every advanced reactor design the U.S. is trying to deploy.
According to RetiredbutWorking, the fair value rests on specific assumptions about future revenue growth, profit margins, and the pricing power that comes with this legal gatekeeper role. Want to see how those expectations translate into that $609.90 figure and why the discount rate matters so much in this model? The full narrative breaks down the cash flow story behind that valuation in clear, concrete terms.
Result: Fair Value of $609.90 (UNDERVALUED)
However, Centrus Energy’s story could be knocked off course if U.S. policy shifts reduce domestic enrichment demand, or if alternative HALEU supply options gain meaningful traction.
Another View: What Centrus Energy’s P/E Ratio Is Telling You
The narrative fair value of $609.90 paints Centrus Energy as heavily undervalued, but the current P/E of 50.7x tells a very different story. It sits well above the estimated fair ratio of 10.4x, the peer average of 10.9x, and the wider US Oil and Gas industry at 13.9x. This points to a lot of optimism already in the price.
For investors, that gap can mean valuation risk if earnings do not progress as expected, or potential upside if the narrative plays out and the market keeps paying a premium multiple. Which version of Centrus Energy do you trust more right now?
Next Steps
Feeling unsure whether Centrus Energy’s mixed signals add up to an opportunity or a warning sign? Act quickly by weighing the data, and then review the 4 important warning signs
Looking for more investment ideas beyond Centrus Energy?
Do not stop with Centrus Energy alone. Broaden your watchlist now so you are not looking back later wishing you had explored more options.
- Target potential mispricings by scanning companies that combine quality with attractive valuations through the 47 high quality undervalued stocks
- Strengthen your income focus by reviewing stocks screened for higher yields and resilient payouts using the 8 dividend fortresses
- Prioritize resilience by zeroing in on companies with lower overall risk profiles through the 82 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
